Drug Database
IS

isosorbide mononitrate (Mono Mack 50D / Mono Mack)

✓ Approved

Novartis AG · Small Molecule · Small Molecule

What is isosorbide mononitrate?

isosorbide mononitrate is a small molecule developed by Novartis AG. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesMono Mack 50D, Mono Mack
CompanyNovartis AG
Drug ClassSmall Molecule
RouteOral (PO)
StatusApproved
Sources: ClinicalTrials.gov, Novartis AG

Therapeutic Indications

isosorbide mononitrate is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Cardiac disordersAngina pectoris✓ Approved

Related Research Articles

PubMedJournal of minimally invasive gynecology2026-07-18

Comparative Resection Efficiency of a Hysteroscopic Tissue Removal System: A Prospective Multicenter Bench Study Using a Standardized Fibroid Model.

Berman Jay M JM, Haimovich Sergio S, Levine David J DJ, Skalnyi Eugene E

To evaluate the resection efficiency of the Aveta hysteroscopic tissue removal system and compare its performance with three established hysteroscopic morcellation devices using a standardized synthetic fibroid model designed to simulate the mechanical resistance of dense leiomyoma tissue. Prospective, multicenter comparative bench study with repeated measures in an incomplete blocks design. Simulated hysteroscopic fibroid resections under standardized conditions. Ninety-one Ob/Gyn practicing physicians routinely performing hysteroscopic myomectomy procedures participated in the study. Simulated hysteroscopic resections using four commercially available hysteroscopic tissue removal systems (Aveta Flex, MyoSure Reach, MyoSure XL, and TruClear Dense Tissue Shaver Plus (DTSP)) were performed in a synthetic fibroid analog tissue model with rheologic properties calibrated to simulate the mechanical resistance of highly fibrotic or partially calcified leiomyomas. Resection efficiency was quantified by measuring the mass of fibroid analog removed in g/min. Ninety-one physicians participated and a total of 220 device observations were included: Aveta Flex (n = 91), MyoSure Reach (n = 56), MyoSure XL (n = 37), and TruClear DTSP (n = 36). Least squares mean resection rates were 0.506 g/min for Aveta Flex, 0.184 g/min for MyoSure Reach, 0.274 g/min for MyoSure XL, and 0.389 g/min for TruClear DTSP. Parametric and nonparametric analyses demonstrated significantly higher resection rates for Aveta Flex compared with MyoSure Reach, MyoSure XL, and TruClear DTSP (mixed-effects model p < .005; Skillings-Mack p < .0001). In this prospective, multicenter study using a standardized synthetic fibroid analog model, the Aveta Flex hysteroscopic tissue removal system demonstrated significantly higher resection efficiency compared with established hysteroscopic morcellation devices. Given the importance of procedural efficiency in operative hysteroscopy, particularly within the limitations imposed by fluid deficit thresholds, these findings may have implications for operative duration, likelihood of complete resection, and overall procedural workflow in hysteroscopic myomectomy.

PMID 42468878
Read full article →
PubMedmedRxiv : the preprint server for health sciences2026-07-17

Heterogeneous Treatment Effects in HFpEF: Distinguishing Drug-Specific Response from Prognostic Phenotypes Across Randomized Trials.

Santana Clodomir C, Katayama Asuka A, Ballal Aditya A, Sirish Padmini P et al.

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome comprising multiple pathophysiological phenotypes. HFpEF trials have largely enrolled diverse populations and reported average treatment effects, consistently yielding neutral results that may obscure drug-specific benefits within distinct subgroups. To address this issue, we employ an interaction-based that incorporates treatment-by-variable interactions to uncover drug-specific responses. We leveraged four HFpEF clinical trials (TOPCAT, RELAX, NEAT-HFpEF, INDIE-HFpEF) and developed a framework comprising two complementary approaches. The first employed a prognostic responder model to evaluate whether conventional responder definitions reflect treatment-specific benefit or instead capture favorable clinical trajectories common to both treatment and placebo groups. The second used an interaction-based individual treatment effect (ITE) modeling to identify baseline variables that modify therapy effect, distinguishing drug-specific response from prognostic phenotypes. Although the prognostic responder model demonstrated good discrimination, further analisys suggested it primarily captured a prognostic signal associated with favorable clinical trajectories common to both treatment and placebo arms. In contrast, the ITE model identified distinct, drug-specific effect modifiers across trials (cardiorenal-inflammatory for spironolactone (TOPCAT), NO-mediated anti-inflammatory for isosorbide mononitrate (NEAT-HFpEF), afterload-reducing for inorganic nitrite (INDIE-HFpEF), and anti-volume-overload for sildenafil (RELAX). Each ITE model demonstrated significance only within its own trial suggesting drug-specific signal. The proposed method identifies mechanism-specific effect modifiers, and uncovers clinically meaningful heterogeneity in treatment response, which is not captured by conventional MCID-based approaches. Although exploratory, these findings support phenotype-guided therapy in HFpEF and argue for phenotype-informed trial design to enhance treatment-effect detection and therapy targeting.

PMID 42465912
Read full article →
PubMedJournal of pharmaceutical sciences2026-07-13

Step-by-step optimization of a colchicine-loaded nanoemulgel for superior topical therapy of acute gouty arthritis.

Zhang Jian J, Xu Xiaqian X, Zhu Anqi A, He Jie J et al.

A colchicine-loaded nanoemulgel (COL-nEMG) was developed for rapid and potent topical therapy of acute gouty arthritis (AGA). An O/W COL-loaded nanoemulsion (COL-nEMS, 14.20 ± 1.73 nm) was first prepared and optimized step by step, including excipient screening, pseudo-ternary phase diagram, in vitro transdermal delivery and D-optimal design. The optimized COL-nEMS containing 10% isosorbide dimethyl ether (DMI) was then dispersed into a gel matrix to produce the final COL-loaded nanoemulgel (COL-nEMG-DMI10). COL-nEMG-DMI10 exhibited a homogeneous appearance, favorable rheological properties, stable three-dimensional porous structure, and good storage stability with a steady-state transdermal flux of 54.6 ± 3.7 µg/cm²/h and 8 h cumulative permeation amount of 425.6 ± 28.3 µg/cm². In an AGA mouse model, COL-nEMG-DMI10 demonstrated rapid therapeutic effects with joint swelling inhibition rate (JSIR) of 37.0 ± 3.4% and maximum possible effect of 37.5 ± 5.3% at 1 h post-administration. In addition, COL-nEMG-DMI10 significantly suppressed the levels of local inflammatory cytokines, including TNF-α and IL-1β, in the ankle joints of AGA animals. This COL-nEMG-DMI10 topical formulation provides a promising treatment strategy for AGA with rapid and pronounced therapeutic efficacy.

PMID 42437588
Read full article →
PubMedActa medica Indonesiana2026-07-09

Anticholinergic Burden, Falls, and the Concept of Appropriate Polypharmacy in Indonesian Geriatric Clinics: A Multicentre Observational Study.

Setiati Siti S, Azwar Muhammad Khifzhon MK, Rensa Rensa R, Sari Nina Kemala NK et al.

A high anticholinergic burden (ACB) scale score (≥3) and polypharmacy have been viewed negatively due to possible adverse events. As Indonesian multicentre data in this field are lacking, this study aimed to provide regional data related to ACB, polypharmacy, and falls, and to analyse factors potentially linked to falls. Data from community-dwelling older adults aged ≥60 years were collected in 12 geriatric care centres through history taking and medical records. Bivariate and multivariate analyses were conducted to evaluate the association between covariates and falls. Polypharmacy and high ACB (score ≥3) were observed in 43.9% and 1.8% of 626 older adults, respectively. The five most prescribed drug classes were calcium-channel blockers, angiotensin receptor blockers, statins, beta blockers, and proton pump inhibitors. The three most prescribed drugs with possible anticholinergic activity were furosemide, isosorbide dinitrate, and cetirizine. The prevalence of past-year falls was 16.8%. Falls were associated with age ≥80 years (odds ratio [OR] 2.44, 95% confidence interval [CI] 1.31-4.53), female sex (OR 2.08, 95% CI 1.30-3.31), transient ischaemic attack and cerebrovascular accident (OR 1.97, 95% CI 0.94-4.10), multimorbidity (≥3 co-morbidities) (OR 1.80, 95% CI 1.07-3.03), depression (OR 1.79, 95% CI 1.00-3.23), and polypharmacy (OR 0.65, 95% CI 0.40-1.05). The prevalence of a high ACB score and falls were 1.8% and 16.8%, respectively. Approximately one in two older adults had polypharmacy. We observed a non-significant inverse relationship between polypharmacy and falls. This may possibly suggest appropriate polypharmacy and closer monitoring applied in geriatric settings, which requires further investigation.

PMID 42421387
Read full article →
PubMedAcademic radiology2026-07-08

AI-Based Longitudinal Scoliosis Monitoring on EOS Whole-Spine Radiographs in a Pediatric to Young Adult Cohort.

Enters Julian J, Zoubi Adham A, Dascalescu Christian C, Endres Felix F et al.

Manual Cobb angle measurement can exhibit high interrater variability, potentially affecting scoliosis management decisions. This study aimed to examine the accuracy of an artificial intelligence (AI) software for automated Cobb angle measurement compared to manual assessments on coronal EOS (EOS Imaging, Paris, France) radiographs of the spine in a pediatric to young adult cohort. In this retrospective single-center study we selected patients from 5-25 years with confirmed scoliosis and multiple follow-up exams. Cobb angles and coronal balance were measured on EOS radiographs: manually by two expert readers, representing the reference standard, and an AI-driven commercial software (IB Lab SQUIRREL, IB Lab GmbH, Vienna, Austria). Performance among readers and the AI was compared using mean differences, intraclass correlation coefficients (ICC), Pearson's correlation coefficients, Skillings-Mack and Bland-Altman analyses. A total of 144 anteroposterior whole-spine EOS radiographs from 29 patients were included (median age 13 years, 8 male). The AI demonstrated excellent agreement with human readers for all measurements (ICCs 0.969-0.993). Mean differences were minimal: (0.2°-0.7°) for Cobb angles and 0.7 mm for coronal balance. Skillings-Mack analysis confirmed no significant temporal drift in AI measurement errors across sequential examinations (all p > 0.05). The AI identified scoliosis progression (increase of or over 5° between measurements) with 90.9% accuracy. AI measurements demonstrated excellent absolute and longitudinal agreement with expert human readers for longitudinal Cobb angle measurement across multiple follow-ups, offering potential for improved diagnostic consistency and efficiency in scoliosis assessment.

PMID 42414133
Read full article →
PubMedZootaxa2026-07-07

New species of Archimonocelididae Meixner, 1938 (Platyhelminthes, Proseriata) from the Pacific Ocean, with the proposal of three new genera.

Schockaert Ernest R ER, Curini-Galletti Marco M

The genera Karlingocelisgen. nov., Martensocelisgen. nov., and Australocelis gen. nov. are introduced for species of Archimonocelididae (Proseriata) characterized by unique features of their sclerotised structures. Species of Karlingocelisgen. nov. possess a short stylet surrounded distally by paired hooks, sitting on strong muscles. Three species from the Pacific are ascribed to the new genus, two of which are new: they may be distinguished by the morphology of their copulatory structures. K. karlingisp. nov. (type species of the new genus) from Australia (Heron Island) has a stylet 110-120 µm long, with one pair of hooks about 60 µm long. The stylet of K. helfrichi (Karling, Mack-Fira and Dorjes, 1972) comb. nov. from the Hawai'i Islands is 54-60 µm long, and is surrounded by two pairs of hooks, about 12 µm long; K. cannonisp. nov. from Australia (Heron Island) has a stylet about 70 µm long, and four pairs of hooks about 25 µm long. The three species have very similar karyotypes, with n=5, and evenly sized chromosomes. Species of Martensocelisgen. nov. have a C-shaped prostate vesicle and a recurve, narrowly tubular stylet with a wide proximal funnel-like opening and surrounded distally by short needles. The type species M. martensisp. nov., from New South Wales, has multiple pharynges and a stylet 150-175 µm long, distally surrounded by a girdle of 30-40 needles, ranging in length 50-80 µm. All other species have a single pharynx. M. justineisp. nov., from New Caledonia, has a stylet 215-230 µm long, and four straight needles 50-55 µm long. M. coffsiasp. nov., from New South Wales, has a stylet 85 µm long, and 10 needles 20-25 µm long, while M. aquilaesp. nov., from Tasmania, has a stylet 95 µm long, less recurve than the other species, and about 10 spines, most of which have very poorly sclerified stalks. M. piscatoris sp. nov., from New South Wales, has a stylet curved to over 180° and 185 µm long, with nine accompanying needles, 75-80 µm long, very slender and with sharp distal tips, and is further provided with two additional needles, about 90 µm long, running from the base of the stylet almost to its distal tip. Species of Australocelis gen. nov. have a straight stylet, and the accompanying needles are symmetrically arranged at either side of the stylet, in groups of different morphology. The type species, A. newmanae sp. nov., from South Australia, has a stylet 70 µm long, and eight needles arranged into two groups; A. rhizophoralis (Martens & Curini-Galletti, 1989) comb. nov., from northern Australia (Darwin, Northern Territory) has a stylet 65 µm long, and 12 needles, arranged into three groups.

PMID 42407711
Read full article →

+4454 more articles available with a free account

Sign up free to view all articles →

Ask about isosorbide mononitrate